Our 2014 approach to breakthrough invasive fungal infections. - Wikidata - wikimedia - TriplyDB

Our 2014 approach to breakthrough invasive fungal infections.

Our 2014 approach to breakthrough invasive fungal infections.

http://www.wikidata.org/entity/Q38223105

about

Invasive mold infections in solid organ transplant recipients A Single Center Experience for Antifungal Prophylaxis in Patients with Acute Myelogenous Leukemia.Prescribing Pattern of Antifungal Medications at a Tertiary Care Hospital in Oman.Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature.A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents.Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study.Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.Invasive mould sinusitis in patients with haematological malignancies: a 10 year single-centre study.

P2860

Q26823811-A7F1B093-E183-4292-9EAF-D410194A4F5D Q35736934-22EAE433-FD8C-4F43-A23A-7EFA1388C9F3 Q37630020-37E71BAB-E5AB-4AA7-B8DD-E86CBF667773 Q38589279-507D5820-5E41-424F-B3E1-D38A72AD00F4 Q38667725-8D0C012A-A443-43D5-AA40-9DACA34E2776 Q39673852-D2049FB9-F416-4924-8EA3-40BBCA6C7081 Q40205895-2E048C02-566D-41DA-9FCA-2E5D56C37D00 Q40562624-B91DB8B6-CDE0-4061-BFF7-D70537C577B3 Q40691888-CFCCEC79-E113-46C3-9B73-CAF04D772D28 Q40722341-8F117337-DA2A-498A-B3C6-54FE41A3D40E

P2860

Our 2014 approach to breakthrough invasive fungal infections.

http://www.wikidata.org/entity/Q38223105

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Our 2014 approach to breakthrough invasive fungal infections.

@en

type

label

Our 2014 approach to breakthrough invasive fungal infections.

@en

prefLabel

Our 2014 approach to breakthrough invasive fungal infections.

@en

P1433

Q38223105-03CA2ECF-3660-4ACC-AB2D-48E6BEA63994

P1476

Q38223105-2F849C66-A57B-4C48-B6FE-568897DDB0CF

P2093

Q38223105-256D2055-D863-4E7C-B0FE-832ACCECD7B4

Q38223105-E9AAA9E4-80B3-4416-8D6E-AF0723EC1D69

P2860

Q38223105-071FA6C8-771A-4CD8-82A8-17D0C979509E

Q38223105-0A0AE8D6-7382-40FF-AB14-A96113EA7885

Q38223105-0A49028A-8186-4071-BF9B-7B5B1ED6A594

Q38223105-0E8A1C34-F9EE-4818-9A79-B6C12C837DD9

Q38223105-137EB9BB-3B3A-4300-9984-282D39166AB9

Q38223105-1B74C0F5-B201-4CC9-8E1B-5739BE138D4E

Q38223105-2165D4E7-3800-4803-87DF-18EA4DA07085

Q38223105-22DDFE49-9282-4E89-901F-9821071F3BF6

Q38223105-242F0BCE-A74A-4430-9D60-860F4521DA26

Q38223105-2B9FC731-D6BF-4814-A176-2BED0B59EBF4

P304

Q38223105-7A569665-81EE-4EC8-B829-E48C84C73869

P31

Q38223105-177E1BF5-B9AE-4F1E-807C-87C2A5D44C6F

P356

Q38223105-1545BBB5-4876-4F8A-8D7D-7D1D7DF93CB3

P433

Q38223105-B855A4BD-7B8B-4D75-9E95-DE79DDA2F207

P478

Q38223105-8A75B333-7131-4DA7-B453-9E9E801272D8

P577

Q38223105-30B787C2-753E-44EA-919A-B6C538F86AE6

P698

Q38223105-01C06515-1863-4AEE-AB64-FB2047192676

P356

P1433

P1476

Our 2014 approach to breakthrough invasive fungal infections.

@en

P2093

Georg Maschmeyer

http://www.w3.org/2001/XMLSchema#string

Thomas F Patterson

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of Candida biofilm drug resistance

Bacterial biofilms: a common cause of persistent infections

Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Breakthrough invasive candidiasis in patients on micafungin.

Heat treatment of amphotericin b modifies its serum pharmacokinetics, tissue distribution, and renal toxicity following administration of a single intravenous dose to rabbits.

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational s

P304

645-651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/MYC.12213

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24963554

http://www.w3.org/2001/XMLSchema#string